ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 17 filers reported holding ARCA BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,971,000 | +17.4% | 1,460,209 | 0.0% | 0.08% | +39.0% |
| Q3 2017 | $1,679,000 | -52.1% | 1,460,209 | 0.0% | 0.06% | -53.9% |
| Q2 2017 | $3,505,000 | -5.9% | 1,460,209 | 0.0% | 0.13% | -1.5% |
| Q1 2017 | $3,724,000 | -10.5% | 1,460,209 | 0.0% | 0.13% | -21.2% |
| Q4 2016 | $4,162,000 | +0.7% | 1,460,209 | 0.0% | 0.16% | -10.8% |
| Q3 2016 | $4,132,000 | -2.4% | 1,460,209 | 0.0% | 0.18% | -15.9% |
| Q2 2016 | $4,235,000 | -16.4% | 1,460,209 | 0.0% | 0.22% | -34.5% |
| Q1 2016 | $5,067,000 | -25.4% | 1,460,209 | 0.0% | 0.34% | -22.2% |
| Q4 2015 | $6,790,000 | -6.3% | 1,460,209 | 0.0% | 0.43% | -9.4% |
| Q3 2015 | $7,243,000 | – | 1,460,209 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 93,258 | $35,000 | 0.02% |
| Tekla Capital Management LLC | 811,227 | $303,000 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 576 | $0 | 0.00% |
| NORTHERN TRUST CORP | 13,986 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 48,679 | $18,000 | 0.00% |
| MORGAN STANLEY | 2,000 | $1,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 219,236 | $82,000 | 0.00% |
| BlackRock Inc. | 865 | $0 | 0.00% |
| Citadel Advisors | 81,938 | $31,000 | 0.00% |